|
|
(HealthNewsDigest.com) – The Food and Drug Administration (FDA) is committed to advancing treatments for rare diseases-medical products, including drugs, that are called orphan products.
FDA’s Office of Orphan Products Development is launching web-based educational resources for patients and industry on FDA-related rare disease topics, in collaboration with the agency’s Center for Drug Evaluation and Research. The first web page will debut Feb. 28, 2014, in recognition of International Rare Disease Day.
Read the Consumer Update to learn more.
FDA Consumer Updates may be posted and published elsewhere without permission. Please credit “FDA Consumer Health Information” as the source. FDA values feedback on its consumer health information. Send questions, comments or story ideas to: [email protected].
Sign up for e-mail notices of new FDA Consumer Updates.
View the FDA Consumer Update RSS feed.
###
For advertising and promotion on HealthNewsDigest.com, call Mike McCurdy: 877-634-9180 or [email protected]. We have over 7,000 journalists as subscribers.